Evidence map›Paper›PMID 33149809›Full record

ArticleOxidative medicine and cellular longevity2020

Epigallocatechin Gallate Effectively Affects Senescence and Anti-SASP via

Stephanie Lilja, Julia Oldenburg, Angelika Pointner, Laura Dewald, Mariam Lerch, Berit Hippe, Olivier Switzeny, Alexander Haslberger

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Five Days Periodic Fasting Elevates Levels of Longevity RelatedInternational journal of molecular sciences · 2021
    Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Stephanie LiljaDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
Julia OldenburgDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
Angelika PointnerDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
Laura DewaldDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
Mariam LerchDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.
Berit HippeHealthBioCare GmbH Nußdorferstraße 67, 1090 Wien, Austria.
Olivier SwitzenyHealthBioCare GmbH Nußdorferstraße 67, 1090 Wien, Austria.
Alexander HaslbergerDepartment of Nutritional Sciences, University of Vienna, 1090 Vienna, Austria.ORCID https://orcid.org/0000-0001-9699-537X
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe investigated different bioactive compounds including epigallocatechin gallate (EGCG), anthocyanidin, resveratrol, phloretin, spermidine, butyrate, and

methodsFor induction of senescence, 3T3-L1 preadipocytes were incubated with bromodeoxyuridine (BrdU) for 8 days. Cell cycle inhibition was observed, and

results

conclusionAccumulation of senescent cells in adipose tissue plays an important role in obesity and age-related diseases.

Indexed as

3T3-L1 CellsAnimalsAnthocyaninsbeta-GalactosidaseBromodeoxyuridineCatechinCell ShapeCellular SenescenceCyclin-Dependent Kinase Inhibitor p21Gene Expression RegulationGenotypeInterleukin-6MiceNF-E2-Related Factor 2PolyphenolsResveratrolAnthocyaninsbeta-GalactosidaseBromodeoxyuridineCatechinCdkn1a protein, mouseCyclin-Dependent Kinase Inhibitor p21epigallocatechin gallateInterleukin-6Nfe2l2 protein, mouseNF-E2-Related Factor 2PolyphenolsResveratrolRNA, MessengerSirtuin 3

Identifiers

PMID33149809
PMCPMC7603628
OpenAlexW3093840514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.